Shares of Unilife spiked this week after it revealed a $60 million debt financing agreement with healthcare investment firm OrbiMed. Unilife CEO Alan Shortall expects to build on those gains as additional deals and customer wins are announced. $40 million was funded to Unilife at the closing of the deal, which it will use to run the business as it moves toward its commercial rollout, while two additional tranches of $10 million each will be provided to Unilife in December 2014 and June 2015.
More from Video
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.
Citi overcame a mixed print to send its stock surging on Monday.